Mitsubishi UFJ Asset Management
BOLD

Mitsubishi UFJ Asset Management’s Audentes Therapeutics, Inc BOLD Stock Holding History

Mitsubishi UFJ Asset Management’s Portfolio BOLD Stock Details BOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-5,041
Closed -$302K – 1026
2019
Q4 		$302K Buy
5,041
+1,244
+33% +$46.7K ﹤0.01% 826
2019
Q3 		$107K Buy
3,797
+743
+24% +$25.4K ﹤0.01% 899
2019
Q2 		$116K Sell
3,054
-3,977
-57% -$153K ﹤0.01% 901
2019
Q1 		$274K Buy
7,031
+751
+12% +$21.5K 0.01% 764
2018
Q4 		$138K Buy
6,280
+1,983
+46% +$51.2K ﹤0.01% 799
2018
Q3 		$170K Buy
+4,297
New +$160K ﹤0.01% 790

Mitsubishi UFJ Asset Management's BOLD Position: Q1 2020 in Review

Mitsubishi UFJ Asset Management sold out of Audentes Therapeutics, Inc (BOLD) in Q1 2020, closing a stake of 5,041 shares — an estimated $302K sold.

Mitsubishi UFJ Asset Management first reported a position in BOLD in Q3 2018 and held it in 6 quarters. The position peaked at $302K in Q4 2019. 0 funds tracked by Wall St. Rank hold BOLD as of Q1 2020.

  • Mitsubishi UFJ Asset Management reported no remaining Audentes Therapeutics, Inc position as of Q1 2020 after selling out during the quarter.
  • Mitsubishi UFJ Asset Management sold 5,041 Audentes Therapeutics, Inc shares in Q1 2020, an estimated $302K.
  • Mitsubishi UFJ Asset Management first reported a position in Audentes Therapeutics, Inc in Q3 2018 and held it in 6 quarters.
  • Mitsubishi UFJ Asset Management's Audentes Therapeutics, Inc position peaked at $302K in Q4 2019.
  • 0 funds tracked by Wall St. Rank held Audentes Therapeutics, Inc as of Q1 2020.

Based on Mitsubishi UFJ Asset Management's 13F filing for Q1 2020, filed 11 May 2020.